For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Ideaya Biosciences Inc (NASDAQ: IDYA) closed at $23.26 up 2.29% from its previous closing price of $22.74. In other words, the price has increased by $2.29 from its previous closing price. On the day, 0.55 million shares were traded. IDYA stock price reached its highest trading level at $24.055 during the session, while it also had its lowest trading level at $23.081.
Ratios:
For a deeper understanding of Ideaya Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.93 and its Current Ratio is at 22.93. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 18, 2024, initiated with a Overweight rating and assigned the stock a target price of $51.
On November 05, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $27.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $50.UBS initiated its Buy rating on October 24, 2024, with a $50 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 26 ’24 when Jason Throne bought 75,000 shares for $40.22 per share.
WHITE MICHAEL ANTHONY sold 28,500 shares of IDYA for $1,032,884 on May 29 ’24. The Chief Scientific Officer now owns 0 shares after completing the transaction at $36.24 per share. On May 15 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 83,856 shares for $42.90 each. As a result, the insider received 3,597,756 and left with 677,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2010403712 and an Enterprise Value of 1109170688. For the stock, the TTM Price-to-Sale (P/S) ratio is 512.86 while its Price-to-Book (P/B) ratio in mrq is 1.70. Its current Enterprise Value per Revenue stands at 282.807 whereas that against EBITDA is -4.989.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.84, which has changed by -0.45204818 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $47.74, while it has fallen to a 52-week low of $22.17. The 50-Day Moving Average of the stock is -13.16%, while the 200-Day Moving Average is calculated to be -33.10%.
Shares Statistics:
For the past three months, IDYA has traded an average of 898.89K shares per day and 847120 over the past ten days. A total of 86.36M shares are outstanding, with a floating share count of 77.42M. Insiders hold about 10.43% of the company’s shares, while institutions hold 99.55% stake in the company. Shares short for IDYA as of 1735603200 were 9999282 with a Short Ratio of 11.12, compared to 1732838400 on 8934689. Therefore, it implies a Short% of Shares Outstanding of 9999282 and a Short% of Float of 12.9.
